Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Monopar Therapeutics Q3 Earnings

Monopar Therapeutics (NASDAQ:MNPR) reported its Q3 earnings results on Thursday, November 9, 2023 at 07:00 AM. Here’s what…
byBenzinga Insights
November 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Monopar Therapeutics (NASDAQ:MNPR) reported its Q3 earnings results on Thursday, November 9, 2023 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Monopar Therapeutics beat estimated earnings by 17.65%, reporting an EPS of $-0.14 versus an estimate of $-0.17.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 5.21% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Monopar Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

A Preview Of Barnes Gr’s Earnings

By Benzinga Insights
October 27, 12:04 PM
Barnes Gr (NYSE:B) is set to give its latest quarterly earnings report on Friday, 2022-10-28. Here's what investors need to know before the announcement. Analysts estimate that Barnes Gr will report an earnings per share (EPS) of $0.49.

B